12/22 H5N1 | Becomes Resistant To Tamiflu/H5N1 Victums Die

=


<B><center>Thursday, December 22, 2005
<A href="http://www.abc.net.au/news/newsitems/200512/s1536601.htm">ABC News.net</a>

<font size=+1 color=red>Deaths show bird flu virus resistant to Tamiflu: study</font></center>
A bird flu virus that killed two people in Vietnam is resistant to the drug that health officials are counting on to halt spread of the disease, according to a study released on Wednesday. </b>

Two new deaths, added to a similar case in October, showed the H5N1 virus was resistant to oseltamivir, sold under the name Tamiflu, according to an article released by the New England Journal of Medicine.

"Resistance can emerge during the currently recommended regimen of oseltamivir therapy," Menno de Jong and team wrote in the article.

"Strategy for the treatment of influenza A (H5N1) virus infection should include additional antiviral agents," the study said.

Tamiflu may kill most, but not all, of the virus in a person's body, the study said. The surviving virus is then resistant to the drug.

"Besides allowing the infection to proceed, such incomplete suppression provides opportunities for drug resistance to develop," the report said.

Up to 18 per cent of children treated with the drug were found to carry resistant variants of the virus, they said.

Two patients who died were 13 and 18-years-old.

Tamiflu is to be administered in the first 48 hours after the onset of symptoms.

The magazine Nature reported that a young Vietnamese girl also showed signs of resistance to the drug, but survived.

The young are especially at risk, if they have never been infected with a similar virus and have never built up a resistance to viruses.

They said higher doses, or delivery of the drug over a longer period, should be studied.
 
=



<B><center>22 December 2005 1219 hrs
<A href="http://www.channelnewsasia.com/stories/afp_asiapacific/view/184908/1/.html">Channlenewsasia.com</a>

<font size=+1 color=brown>Indonesia confirms two more human bird flu fatalities </font></center>
JAKARTA : An Indonesian man and boy have been confirmed by World Health Organisation tests as having died of bird flu, bringing the country's death toll from the virus to 11, a hospital spokesman said on Thursday. </b>

Asked whether test results on the pair had been received from a Hong Kong laboratory, Sulianti Saroso hospital spokesman Ilham Patu told AFP: "It's been confirmed. We were informed of the results this morning.

"So we have now 16 confirmed cases and 11 deaths," he said. Five people have survived infection of the virus. - AFP/de
 
=



<B><font size=+1 color=green><center>Strain of bird flu resistant to Tamiflu kills two patients </font>

By Liz Szabo
<A href="http://www.usatoday.com/news/health/2005-12-21-bird-flu_x.htm">USA TODAY.com</a></center>
Two Vietnamese patients have died after developing strains of bird flu that were resistant to Tamiflu, the antiviral drug that nations around the world are stockpiling in the hope of saving lives if a global pandemic occurs.</b>
Their deaths, which took place in January, were reported Thursday in The New England Journal of Medicine. A third patient, a 14-year-old Vietnamese girl whose case was reported in Nature in October, also developed resistance but survived.

Health officials had predicted that the bird flu virus, H5N1, would evolve into resistant forms, which happens often with virus-fighting medications. But experts also say the deaths are a warning that countries are not yet prepared to deal with a pandemic.

Experts are unsure whether a flu pandemic is imminent, but they fear that the H5N1 virus could trigger one if it becomes highly contagious.

Fifty countries are stockpiling Tamiflu, which can be used to treat and prevent infections. Tamiflu's maker, Roche, announced Wednesday that U.S. regulators would allow it to market the drug to prevent flu in children ages 1 through 12, Reuters reported.

Roche can now produce enough of the drug to treat 65 million people but will make enough for 300 million patients by the end of 2006, says David Reddy, leader of Roche's influenza pandemic task force.

It still makes sense for countries to stockpile the drug because most patients respond to Tamiflu, says Arnold Monto, a professor of epidemiology at the University of Michigan School of Public Health. The New England Journal article said four of eight Vietnamese patients treated with Tamiflu survived.

But the study suggests doctors might need to use higher doses to prevent resistance, Reddy says. Roche plans to work with the World Health Organization and the National Institutes of Health on a trial that would give patients twice the standard dose of Tamiflu.

If that dose proves effective, nations might need to double their planned stockpiles, says Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota. For now, he says, doctors just don't know the ideal dose.

Doctors might need to find other ways to treat bird flu should there be a pandemic. The same genetic changes that make the virus more contagious also could make it less deadly, Reddy adds.

Beyond Tamiflu, the Infectious Diseases Society of America recommends stockpiling another antiviral, Relenza, says Andrew Pavia, a member of the group's task force on pandemic flu. Unlike Tamiflu, which is in pill form, Relenza is given through an inhaler and is harder to administer, especially to patients who are unconscious. Researchers are testing an injectable form.

People who misuse Tamiflu or stockpile it themselves could waste the drug or harm themselves by developing resistance, say doctors Allan Brett and Abigail Zuger in an editorial accompanying the New England Journal article.
 
=



<B><center>Flu pandemic: new doubts over key drug

<font size=+1 color=blue>Studies show resistance to Tamiflu </font>

Sarah Boseley, health editor
Thursday December 22, 2005
The Guardian </a></center>
Serious questions are raised today about the ability to combat an anticipated bird flu pandemic following the deaths of two people who were being treated with the drug the world is stockpiling as a safeguard against the virus.</b>
To the dismay of medical experts and concern among those responsible for the worldwide efforts to fight a pandemic, the H5N1 bird flu virus in the bloodstream of the two patients in Vietnam rapidly developed resistance to the drug, Tamiflu. One, a 13 year-old girl, appeared to be stable at first and then rapidly worsened as the virus mutated, became more aggressive, and eventually killed her.
 
=



<B><center>Bird flu patients develop resistance to Tamiflu

<font size=+1 color=purple>Two girls with bird flu died despite early and aggressive treatment with the drug, which is believed to be the frontline of defense to combat the disease.</font>

Alicia Chang, Associated Press
December 21, 2005 at 8:46 PM
<A href="http://www.startribune.com/stories/722/5796126.html">Startribune.com</a></center>
In a development health experts are calling alarming, two bird flu patients in Vietnam died after developing resistance to Tamiflu, the key drug that governments are stockpiling in case of a large-scale outbreak.</b>

The experts said the deaths were disturbing because the two girls had received early and aggressive treatment with Tamiflu and had gotten the recommended doses.

The new report suggests that the doses doctors now consider ideal may be too little. Previous reports of resistance involved people who had taken the drug in low doses; inadequate doses of medicine are known to promote resistance by allowing viruses or bacteria to mutate and make a resurgence.

Dr. Anne Moscona, a flu expert at Weill Cornell Medical College in New York City, called the deaths frightening and said they demonstrate the dangers of hoarding drugs. "People who stockpile will naturally share or take drugs at the wrong dose, and that's really a bad idea," said Moscona, who wrote an accompanying commentary in today's New England Journal of Medicine.

Since 2003, avian flu has killed about 70 people, mostly in Vietnam and Thailand, and nearly all involved close contact with infected birds. Health experts fear the virus could morph into a form that spreads easily between people.

Tamiflu and another drug, Relenza, are expected to be the front-line defense if that happens, but they must be taken soon after infection to be effective. Tamiflu, made by Swiss-based Roche Holding AG, is the favored drug because it appears to be effective against all kinds of flu, including bird flu. GlaxoSmithKline's Relenza requires an inhaler and has not been widely tested in people with avian flu.

Concerns about Tamiflu resistance surfaced in October when doctors discovered it in a Vietnamese girl, 14, who had been given low doses as a precaution because she was caring for a brother with bird flu. She survived, and doctors theorized the low doses caused the resistance.

The new report involved eight Vietnamese bird flu patients given Tamiflu upon being hospitalized in 2004 or 2005. Half of the patients died. Lab tests showed two of those who died -- girls ages 13 and 18 -- had developed resistance.

In the case of the 13-year-old, doctors were especially surprised to see resistance because she was treated within the time frame when the drug was supposed to be most effective.

The study was led by Dr. Menno de Jong of Oxford University.

David Reddy, who heads Roche's influenza pandemic task force, said the study merits further investigation into whether patients need more of the drug.

Roche is conducting animal studies of different dosages to see which works best. Results are expected early next year. In addition, Roche is working with the World Health Organization and the National Institutes of Health to begin a human experiment next year that would test whether doubling the current recommended dose of Tamiflu is more effective, Reddy said.

Bird flu has some health experts worrying about the hoarding of Tamiflu, which is in tight supply as countries scramble to stock up.

In October, Roche announced it was suspending shipments to U.S. wholesalers and other private-sector recipients to ensure enough Tamiflu for the regular flu season. Roche is also negotiating with other companies to increase production.
 
=


<B><font size=+1 color=red><center>Bird flu victims developed resistance to Tamiflu drug </font>

By ALICIA CHANG, Associated Press writer
<A href="http://www.southcoasttoday.com/daily/12-05/12-22-05/a09wn248.htm">southcoasttoday.com</a></center>
In a development health experts are calling alarming, two bird flu patients in Vietnam died after developing resistance to Tamiflu, the key drug that governments are stockpiling in case of a large-scale outbreak. </b>

The experts said that the deaths were disturbing because the two girls had received early and aggressive treatment with Tamiflu and had gotten the recommended doses.

The new report suggests that the doses doctors now consider ideal may be too little. Previous reports of resistance involved people who had taken the drug in low doses; inadequate doses of medicine are known to promote resistance by allowing viruses or bacteria to mutate and make a resurgence.

Dr. Anne Moscona, a flu expert at Weill Cornell Medical College in New York City, called the deaths frightening and said they demonstrate the dangers of hoarding drugs.

"People who stockpile will naturally share or take drugs at the wrong dose, and that's really a bad idea," said Moscona, who wrote an accompanying commentary in today's New England Journal of Medicine.

Since 2003, avian flu has killed about 70 people, mostly in Vietnam and Thailand, and nearly all involved close contact with infected birds. Health experts fear the virus could morph into a form that spreads easily between people.

Tamiflu and another drug, Relenza, are expected to be the front-line defense if that happens, but they must be taken soon after infection to be effective.

Tamiflu, made by Swiss-based Roche Holding AG, is the favored drug because it appears to be effective against all kinds of flu, including bird flu. GlaxoSmithKline's Relenza requires an inhaler and has not been widely tested in people with avian flu.

Concerns about Tamiflu resistance surfaced in October when doctors discovered it in a 14-year-old Vietnamese girl who had been given low doses as a precaution because she was caring for a brother with bird flu. She survived, and doctors theorized the low doses caused the resistance.

The new report involved eight Vietnamese bird flu patients given Tamiflu upon being hospitalized in 2004 or 2005. Half of the patients died. Lab tests showed two of those who died -- girls ages 13 and 18 -- had developed resistance.
In the case of the 13-year-old, doctors were especially surprised to see resistance because she was treated within the time frame when the drug was supposed to be most effective.

The study was led by Dr. Menno de Jong of Oxford University.
David Reddy, who heads Roche's influenza pandemic task force, said the study merits further investigation into whether patients need more of the drug.
Roche is conducting animal studies of different dosages to see which works best. Results are expected early next year.

In addition, Roche is working with the World Health Organization and the National Institutes of Health to begin a human experiment next year that would test whether doubling the current recommended Tamiflu dose is more effective, Reddy said.

Bird flu has some health experts worrying about hoarding of Tamiflu, which is tight supply as countries scramble to stock up.

In October, Roche announced it was suspending shipments to U.S. wholesalers and other private-sector recipients to ensure enough Tamiflu for the regular flu season. Roche is also negotiating with other companies to increase production.
 
=


<B><font size=+1 color=brown><center>UN urges RI to anticipate bird flu pandemic </font>

Tb. Arie Rukmantara, T
<A href="http://www.thejakartapost.com/detailnational.asp?fileid=20051222.C04&irec=3">The Jakarta Post, Jakarta</a>
December 22 2005</center>
The United Nations (UN) urged Indonesia to prepare a contingency plan for the possibility of the avian influenza turning into a global pandemic, a senior UN official said.</b>

UN systems senior coordinator for avian and human influenza David Nabarro said a pandemic of the H5N1 bird flu strain could occur at any time and any place and therefore urged the Indonesian government to start developing a plan for such an eventuality.

"It will happen at some point. Act as though a pandemic will start tomorrow. Don't assume we can wait around and not worry that it won't start in the next six months or one year. If we do, once it starts it will be too late to prepare and we will all will be in crisis," he said at a recent workshop on avian influenza pandemic contingency plans held at the Office of the Coordinating Minister for People's Welfare on Monday.

He warned that should there be a pandemic, it would threaten half the world's population as no medication would be able to stem the tide of illness.

"At that stage, the virus may be resistant to Tamiflu, so we can't rely on Tamiflu," he said, referring to the drug currently given to bird flu patients.

The highly pathogenic H5N1 strain remains a virus essentially in birds. However, scientists fear that it could mutate into a form that could pass easily from human to human.

The government said that as of July, the country was in phase three of the six phases of a flu pandemic, meaning there was the possibility of facing a new subtype of the virus.

There have been bird flu breakouts in Indonesia, Cambodia, China, Laos, Thailand and Vietnam since August 2003. To date, there have been nine confirmed bird flu deaths in Indonesia and more than 10 million poultry killed.

Nabarro stressed the danger of a poor response to the possibility of an outbreak and pointed out that the 1918 Spanish flu was caused by the H1N1 subtype virus and killed 40 million people across the globe.

"To cope with such a threat, we should prevent, prepare and respond," he said.

Coordinating Minister for People's Welfare Aburizal Bakrie said that the government had formulated a plan to control avian influenza and to cope with a possible flu pandemic.

"Among other things, in the near future we will set up an integrated and autonomous organization to do tangible work to prevent and cope with any flu pandemic," he said.

The "National Strategic Plan to Control Avian Influenza and Preparedness to Face a Influenza Pandemic, 2006-2008" proposal says the government will introduce more than a dozen strategies to control the bird flu, including organizing mass culls and poultry vaccinations as well as increasing the stockpile of antiviral drugs and organizing research on bird flu vaccines.

Should a pandemic occur, the government proposal says it will isolate areas in which 80 percent of the population is infected and will mobilize manpower, including soldiers and police officers, to help limit the pandemic spread.

However, Aburizal said he did not know how much money would be needed to finance the implementation of the plan.

"All we have at present is US$150 million, which was agreed upon during the last WHO meeting in Geneva, and the government will add another $10 to $20 million," he said, adding that international aid would be needed to support the government's drive.

Deputy to the State Minister of National Development Planning Dedi M. Masykur Riyadi, whose office drafted the proposal, said should all of the strategies be implemented, the government would need about Rp 15.7 trillion ($1.5 billion) from 2006 to 2008.
 
=



<B><font size=+1 color=green><center>Lack of Human Immunity Makes Bird Flu More Worrisome </font>

Wednesday, December 21, 2005
By Catherine Donaldson-Evans
<A href="http://www.foxnews.com/story/0,2933,179439,00.html">FOXNews.com</a></center>
Tamiflu May Not Be Reliable Bird Flu Protection, DHS Official Warns
Amidst all the frenzy over the bird flu virus that's raging among poultry and has killed 71 people since its onset, the issue of human immunity tops the list of grave concerns. </b>

Because the avian flu that’s spreading rapidly among birds in Asia and now parts of Europe is a never-before-seen strain of H5N1, human beings have no natural immunity to it — and thus no way for their bodies to fight it off should it mutate into a disease that can be passed from person to person.

“People do not have any defenses against this virus because it is entirely new,” said Jennifer Morcone, a spokeswoman for the Centers for Disease Control (CDC). “It’s not like the other flu viruses that have circulated in the past.”

Scientists and physicians know for sure that human beings don't have any natural immunity to H5N1 because they've measured and analyzed the antibodies in patients' blood serum.

To date, everyone who has fallen ill with this form of avian flu has caught it by handling or coming into close contact with infected birds. So far, there have been 139 confirmed human cases reported since 2003, when the illness was first discovered, and 71 deaths — a 51 percent mortality rate, according to the World Health Organization’s Dec. 16 figures.

In order for bird flu to mutate so that people can catch it from each other, an infected person has to be carrying another type of human-to-human flu bug at the same time that he or she catches the bird flu, so that the two influenza strains can swap genes.

"The avian flu picks up some genes from the other flu," said Dr. Herbert L. DuPont, director of the Center for Infectious Diseases at the University of Texas School of Public Health. "This has happened three times in the past 100 years."

All three pandemic flus of the 20th century originated from birds. The legendary 1918 Spanish flu took between 20 and 50 million lives, up to 675,000 of them in the United States; the Asian flu of 1957 killed 2 million worldwide, 70,000 in the U.S.; and the Hong Kong flu of 1968 killed 1 million worldwide, 34,000 in the U.S.

With that history in mind, what worries immunologists and other health experts is the fact that the existing form of avian flu is voraciously infecting birds across a wide swath of the globe.

The H5N1 virus initially emerged in poultry in 1996 and the first human cases and deaths were reported in 1997 in Hong Kong. Alarming, widespread poultry outbreaks began happening in 2003, which was also the onset of more human cases in Hong Kong and Vietnam.

Since then, the disease has spread to Thailand, China, Indonesia and Cambodia — where the other human deaths have occurred — and also to Japan, Laos, Korea, Malaysia, Croatia, Kazakhstan, Mongolia, the Philippines, Romania, Russia, Turkey and the Ukraine.

"It is a real threat because we know this is a virus that just this year has spread to three different countries in Asia," Morcone said, referring to China, Indonesia and Cambodia, the countries where human deaths have been reported in 2005.

That means it's just a matter of time before this H5N1 will travel closer to home.

“Eventually, when you have migrations of birds, you’re going to get some cases in North America,” said Dr. Gilbert Ross, medical director at the American Council on Science and Health.

In addition, unlike other flu viruses that are generally only fatal among the elderly and infirm, this influenza strain has been killing younger people — much like the 1918 outbreak. That is in part because most of those afflicted were bird handlers in their 20s to 40s, but it also could be an indication that this strain is similar to the devastating disease of the early 20th century, which was an H1 flu.

"Fifty percent of the people who died in 1918 were between the ages of 20 and 40," said Dr. Ed Septimus, medical director of infectious disease at the Memorial Hermann Healthcare System, a cluster of hospitals in the Houston region. "We're seeing a similar mortality rate and younger people being infected and dying."

Influenza is notorious among diseases for its frequent changes, or drifts, in strain, meaning it is difficult to immunize against via one of the two main ways immunity occurs — by vaccine or by infection with the illness.

The run-of-the-mill flu that makes an appearance every year is constantly mutating, so a new vaccine needs to be developed annually to combat whatever strain is the most prevalent in the community during that season. It's a challenge to doctors and scientists, who sometimes come up with a less effective vaccine because of the unstable nature of influenza.

“Your best protection is when the vaccine matches the strain that is circulating in the community,” Septimus said. “In the past few years, the predominant flu bug in the community was not in the vaccine; it was a mismatch. We guessed wrong. But that still gave about 50 percent protection. If it had been a match, it would have been about 80 percent.”

The drifts in the regular cold-weather flu differ from the larger "shifts" in the virus, which happen when the hemoglobin — the H in the scientific name for the strain — changes entirely. This current H5N1 avian flu is new because an H5 had never been seen before.

"When the hemoglobin changes, it's a big deal," DuPont said. "When it shifts and goes to a completely different hemoglobin, there's no existing immunity and we have pandemic flu."

The so-called "shift-and-drift" nature of the flu also means that human beings who get their shots or catch that particular bug are only protected from that one specific strain during that one specific time. Unlike immunity to most other diseases, immunity to influenza is fleeting.

“The protective immunity against flu is four months from the influenza vaccine — you have protective levels of the antibody for approximately four months,” DuPont said. “That’s why people who get the vaccine in the early part of the season can still get the flu in the later part of the season.”

Immunity is built up when parts of the virus in question are introduced into the body, either because the person has become infected or has been vaccinated. The human system then builds up antibodies to ward the illness off.

There are two types of human vaccines: live vaccines and killed ones. Most flu vaccines are killed, meaning the agent in them is dead and can no longer be grown in a lab, but still produces antibodies and protects against the virus. Vaccines for illnesses like measles, mumps and rubella are live, made with a less virulent strain of the virus that's processed in such a way so as not to cause sickness, while still providing immunity and having the ability to keep growing in a lab.

Many people are exposed to sicknesses of various stripes without ever having any symptoms, as is the case with “the kissing disease” known as mononucleosis. Of every 1,000 people infected with mono, only five unlucky ones actually fall ill from it — but all are immune, according to DuPont.

“The most common way to build up immunity is to have an infection with the agent, and most agents do not produce clinical disease when they infect,” he said.

Immunity to illnesses like mono, chicken pox (which is the varicella virus), measles, mumps, polio and smallpox is generally long-lasting among people, with those infected or vaccinated having protection that can last at least a generation, if not a lifetime.

In fact, even when a human immune system hasn't seen a virus for decades and then is reintroduced to it decades later, "memory cells" in the body will often recall it and begin to quickly develop antibodies to fight it off, meaning the person will either not get sick at all or will have a much milder form of the disease.

"Sometimes, seeing a virus that's similar will wake up a dormant immune system and produce antibodies very quickly in response to a challenge from a virus," Septimus said. "It may have an effect on how severely you become ill and the expression of the illness."

Human immunity does diminish slowly over time, but with most diseases other than influenza, exposure to an illness provides at least partial immunity for years even when it has decreased from what it was originally. Flu, of course, is the black sheep.

But experts are trying to soothe those frightened by the current avian influenza that has an increasingly large part of the world in its grips, saying there is hope for a flu shot to be developed that will successfully ward it off.

"We will see an effective vaccine, just like we've seen effective vaccines for nearly every other communicable disease except HIV and malaria," said the American Council's Ross.

He and others in the field urge that in the meantime, the immediate focus should be on taking precautions, both against bird flu and the regular garden variety that's crept up on us again this wintry season.

"If they're traveling to Asia, we recommend that people don't visit live bird markets and don't go to bird farms, be mindful of the food they eat and mindful that food is cooked," said the CDC's Morcone.

Avian influenza aside, the best advice could also be the best medicine: Wash your hands frequently, especially when you're sick with the flu or a flu-type bug, stay home until you get well and cover your mouth when you cough and splutter.

"Let's not get hung up on bird flu, which may not happen — and if it happens we don't know when," Septimus said. "Do what you're supposed to do this year, and let the scientists and government work out a plan for the potential of a pandemic."
 
=



<B><font size=+1 color=blue><center>Bird flu 'resisting antidote' </font>

December 22 2005
<A href="http://www.ananova.com/news/story/sm_1656565.html">Ananova.com</a></center>
New doubts over the drug used to combat bird flu have emerged as two people died after failing to respond to the treatment, scientists have revealed.</b>

A study of 13 Vietnamese patients infected with the H5N1 strain of bird flu found two developed a rapid resistance to the anti-viral drug, Tamiflu, which led to their deaths.

The report published in the New England Journal of Medicine was described as "frightening" by medical experts.

Governments around the world are stockpiling Tamiflu amid fears that bird flu will mutate into a form that is more easily spread between humans, leading to a pandemic.

The Department of Health is stockpiling 14.6 million courses of the drug, which was hoped would shorten the length of illness and reduce the symptoms.

The deadly H5N1 virus has so far killed 71 people in south east Asia.

Researchers at the Oxford University Clinical Research Unit working in Vietnam also warned that other anti-viral drugs apart from Tamiflu may be needed.

They fear that people taking the wrong dose of Tamiflu may contribute to the growth of a resistant virus strain.

Leading virologist Sir John Skehel, director of the National Institute for Medical Research in London, urged the Government to broaden the UK's defence by looking at other option such as the inhaled drug Relenza.

He said: "The fear is that all the virus that comes here might be resistant. We should be stockpiling other drugs. Some of these mutations are only resistant to Tamiflu. But I am not aware how much Relenza is available."
 
=



<B><font size=+1 color=purple><center>Bird flu strain develops resistance to drug stockpiled by Britain </font>

By Jeremy Laurance, Health Editor
Published: 22 December 2005
<A href="http://news.independent.co.uk/uk/health_medical/article334689.ece">IndependantOnline.com</a></center>
The only drug available against a threatened pandemic of avian flu may be useless for many of those infected and could make the pandemic worse, scientists fear.

The warning came after a study of 13 Vietnamese patients infected with avian flu (H5N1) who were treated with the anti-viral drug, Tamiflu, found two developed a resistant virus strain which contributed to their deaths. In all, seven of the 13 patients died. The New England Journal of Medicine, which publishes the findings today, describes them as frightening.</b>

Governments around the world, including the UK, are stockpiling Tamiflu to be used as the first line of defence against a flu pandemic.

But indiscriminate use of the drug in the event of a pandemic could fuel the growth of a resistant virus strain, triggering a second wave of infection against which there would be no defence, researchers say. Yesterday, Sir John Skehel, director of the National Institute for Medical Research in London, and one of the world's leading virologists, said: "The fear is that all the virus that comes here might be resistant."

Sir John said Tamiflu was better at preventing infection with flu than treating it. "It's a prophylactic not a therapeutic."

He urged the Government to broaden the UK's defence. Relenza, an inhaled drug which works in a similar way to Tamiflu, has not shown signs of triggering resistance but it has been ignored because it is harder to take. "We should be stockpiling other drugs. Some of these mutations are only resistant to Tamiflu. But I am not aware how much Relenza is available," Sir John said.

The H5N1 virus has infected 138 people in the Far East and killed 71 but the fear is it could mutate to become transmissible among humans.

In the Vietnamese study, one of the patients, a 13-year-old girl whose mother had died of avian flu, was treated with a high dose of Tamiflu within 24 hours of developing a cough and fever, when "the greatest clinical benefit could have been expected". But although her condition improved at first, it later worsened and she died eight days after starting treatment. A resistant virus strain was isolated and at the time of her death the amount of virus in her throat had increased.

The second patient died after 14 days, also showing signs of an increase in the amount of virus.

The two cases follow an earlier report of partial resistance in a Vietnamese patient infected with avian flu last February, who was given preventive treatment with the drug at a lower dose. In that case, the patient survived.

Professor Anne Moscona of Cornell University says in the journal that the Vietnamese cases "raise the worrisome prospect that even with therapeutic doses", resistance to Tamiflu may emerge.

Dosages may need to be raised and treatments combining several different drugs used, Professor Moscona says. Personal stockpiling of Tamiflu could lead to sharing of drugs, leading to under-dosing of infections, which could in turn fuel the pandemic.

The only drug available against a threatened pandemic of avian flu may be useless for many of those infected and could make the pandemic worse, scientists fear.

The warning came after a study of 13 Vietnamese patients infected with avian flu (H5N1) who were treated with the anti-viral drug, Tamiflu, found two developed a resistant virus strain which contributed to their deaths. In all, seven of the 13 patients died. The New England Journal of Medicine, which publishes the findings today, describes them as frightening.

Governments around the world, including the UK, are stockpiling Tamiflu to be used as the first line of defence against a flu pandemic.

But indiscriminate use of the drug in the event of a pandemic could fuel the growth of a resistant virus strain, triggering a second wave of infection against which there would be no defence, researchers say. Yesterday, Sir John Skehel, director of the National Institute for Medical Research in London, and one of the world's leading virologists, said: "The fear is that all the virus that comes here might be resistant."

Sir John said Tamiflu was better at preventing infection with flu than treating it. "It's a prophylactic not a therapeutic."

He urged the Government to broaden the UK's defence. Relenza, an inhaled drug which works in a similar way to Tamiflu, has not shown signs of triggering resistance but it has been ignored because it is harder to take. "We should be stockpiling other drugs. Some of these mutations are only resistant to Tamiflu. But I am not aware how much Relenza is available," Sir John said.
The H5N1 virus has infected 138 people in the Far East and killed 71 but the fear is it could mutate to become transmissible among humans.

In the Vietnamese study, one of the patients, a 13-year-old girl whose mother had died of avian flu, was treated with a high dose of Tamiflu within 24 hours of developing a cough and fever, when "the greatest clinical benefit could have been expected". But although her condition improved at first, it later worsened and she died eight days after starting treatment. A resistant virus strain was isolated and at the time of her death the amount of virus in her throat had increased.

The second patient died after 14 days, also showing signs of an increase in the amount of virus.

The two cases follow an earlier report of partial resistance in a Vietnamese patient infected with avian flu last February, who was given preventive treatment with the drug at a lower dose. In that case, the patient survived.

Professor Anne Moscona of Cornell University says in the journal that the Vietnamese cases "raise the worrisome prospect that even with therapeutic doses", resistance to Tamiflu may emerge.

Dosages may need to be raised and treatments combining several different drugs used, Professor Moscona says. Personal stockpiling of Tamiflu could lead to sharing of drugs, leading to under-dosing of infections, which could in turn fuel the pandemic.
 
=



<B><font size=+1 color=red><center>New outbreak of bird flu confirmed in Romania</font>

December 22 2005
<A href="http://english.peopledaily.com.cn/200512/22/eng20051222_229952.html">People's Daily Online</a></center>
A new outbreak of bird flu was detected in the southeastern Romanian village of Chichinetu on Tuesday, the 19th case since the epidemic first broke out in the country in October, its official radio station reported on Wednesday. </B>

"The laboratory in Bucharest (Romania's capital) on Tuesday confirmed the presence of the H5 virus in poultry in Chichinetu, with dozens of fowl affected," Chief of the Veterinary Health Bureau Gabriel Predoi told the radio.

Local government officials have been slaughtering all poultry from the village and have set in place decontamination measures throughout the area. Precautionary measures have also been taken in Bucharest, however, the risk of the epidemic spreading is still high, health authority official Teodora Ciolompea warned.

Five of Romania's 41 counties have been hit by bird flu, including Ialomita which is only 70 to 80 km away from Bucharest.

More than 100,000 head of poultry have been slaughtered in Romania since the first case was discovered on October 7.

Most of the cases in Romania were detected in the Danube river delta to the east, located on a major migration path of wild birds. Predoi suggested local farmers should raise poultry indoors instead of in the wild, to reduce the risk of being affected by the deadly virus.

Source: Xinhua
 
=



<B><font size=+1 color=red><center>Vietnam reports new bird flu outbreaks</font>

<A href="http://news.xinhuanet.com/english/2005-12/22/content_3955228.htm">www.chinaview.cn</a>
2005-12-22 10:53:05 </center>
HANOI, Dec. 22 (Xinhuanet) -- Vietnam's central Quang Nam province has just been stricken by bird flu, raising the total number of affected localities since early October to 22nd of this month, according to local newspaper Young People on Thursday. </b>

Three out of dozens of samples from fowls in the three communes of the two districts of Thang Binh and Nui Thanh were tested positive to bird flu virus strain H5N1, the newspaper quoted Nguyen Ngoc Quang, vice chairman of the provincial People's Committee, as saying.

The committee has decided to cull all poultry in the three communes to prevent the disease from spreading. However, Quang Namhas yet to find suitable locations for burying the poultry, since many areas in the province are being flooded with rainwater and river water.

On Wednesday, the Department of Animal Health under Vietnam's Ministry of Agriculture and Rural Development announced that nine localities have met the criteria (detecting no new outbreaks for at least three weeks), namely Bac Giang, Hoa Binh, Thai Binh, HungYen, Long An, Hai Duong, Phu Tho, Quang Ninh and Bac Ninh.

Since Oct. 1, a total of 22 cities and provinces of Vietnam have been hit by bird flu, which has killed and led to the forced culling of nearly 3.7 million fowls.

In order to prevent the disease from spreading, the ministry has recently proposed the government allow the slaughter of all ducks, which are raised freely in fields and canals. Enditem
 

okie medicvet

Inactive
Man I don't know why I'm not surprised that birds now have a version of the flu that are tamiflu resistant..but for some reason I saw that one coming..I don't think there will be any medicine able to treat it..only the symptoms if that.
 

fairbanksb

Freedom Isn't Free
I think I remember reading somewhere that the bird flu was becoming resistant to Tamiflu. Is there any truth to that?
 

Bill P

Inactive
The above information (esp wrt tamiflu resistance) doesnt track well with previous information:

It has been well publicized for months that no one has anti-bodies to H5N1 - that in and of itself is no longer newsworthy.

It has also been well publicized that the High Pathogenic Avian Influenza H5N1 is more virulent than other virii. The H5N1 replicates in greater numbers in a give span of time.

Tamiflu and Relenza do not "kill" the virus. These antivirals put a coating on infected cells that make it difficult for new copies of the H5N1 to escape the infected cell and enter the bloodstream. Tamiflu is likened to a sheet of fly paper - it is a passive coating that prevents most of the H5N1 from entering the bloodstream. Since the anti-virals work on the replicated copies after they have been created in the infected cell - it would be difficult for the new virus copies to have had any contact with the anti-viral medication.

So "resistance" has a totally different meaning than bacterial resistance to an anti-biotic. My read is "resistance" to H5N1 means that admistration of the anti-viral failed to prevent the death or the depth of illness, meaning it had little effect on the course of the disease. This could be becuase it was given too late in the course of the disease or in insuffieceint quanty to provide sufficient protection of infected cells.

Roche and the WHO have previously announced that due to the virulence and enhanced replacation rates of the H5N1 the dosages of tamiflu need to be doubled.

The part about '"stockpilers" abusing the dosages' is pure BS - all Rx meds taken at home are self administered. Stockpilers are no more likely to abuse the dosage than anyone else with a prescription. It appears there is a panic over the availability of the anti-virals and some PTB are trying to nip stockpiling to make the med available elsewhere. In the end, if the med is used to combat the flu, it wont matter whether it was acquiered by Rx or by stockpiling.


BTW - I have some Dutch ancestry on my father's mother's side....
 
Top